Andrew O’Sullivan
Impact in
-
- Inhalation and Respiratory Drug Delivery
- Infection Control and Ventilation
- Neonatal Respiratory Health Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Respiratory Support and Mechanisms
-
- Obesity and Health Practices
Papers in
-
- Inhalation and Respiratory Drug Delivery 12
- Infection Control and Ventilation 4
- Neonatal Respiratory Health Research 3
- Respiratory Support and Mechanisms 1
- Cystic Fibrosis Research Advances 1
- Co-authors
- Ronan MacLoughlin (15 shared papers)Mary Joyce (10 shared papers)James A. McGrath (6 shared papers)Gerry Oster (1 shared paper)John Edelsberg (1 shared paper)Miriam Byrne (5 shared papers)David R. Thompson (1 shared paper)Marc Mac Giolla Eain (5 shared papers)
- Journals
- Pharmaceutics (4 papers)Frontiers in Medicine (2 papers)Antibiotics (1 paper)Vaccines (1 paper)European Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- IrelandUnited StatesUnited Kingdom
In The Last Decade
Andrew O’Sullivan
14 papers receiving 203 citations
Peers
Comparison fields: 5 of 54
- Pulmonary and Respiratory Medicine 121
- Pharmacy 13
- General Dentistry 4
- Pharmaceutical Science 14
- Critical Care and Intensive Care Medicine 5
Countries citing papers authored by Andrew O’Sullivan
This map shows the geographic impact of Andrew O’Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew O’Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew O’Sullivan more than expected).
Fields of papers citing papers by Andrew O’Sullivan
This network shows the impact of papers produced by Andrew O’Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew O’Sullivan. The network helps show where Andrew O’Sullivan may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew O’Sullivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The clinical and economic burden of obesity in a managed care setting. | 2000 | 47 |
| 2 | 2019 | 43 | |
| 3 | 2022 | 24 | |
| 4 | 2021 | 19 | |
| 5 | 2021 | 15 | |
| 6 | 2021 | 14 | |
| 7 | 2021 | 14 | |
| 8 | 2021 | 10 | |
| 9 | 2024 | 7 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 4 | |
| 12 | 2020 | 4 | |
| 13 | 2022 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 2024 | 0 | |
| 16 | 2023 | 0 |
About Andrew O’Sullivan
Andrew O’Sullivan is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health, Health, Toxicology and Mutagenesis, Surgery and Molecular Biology, having authored 16 papers that have together received 211 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (12 papers), Infection Control and Ventilation (4 papers), Neonatal Respiratory Health Research (3 papers), Climate Change and Health Impacts (2 papers), Respiratory Support and Mechanisms (1 paper), Immunotherapy and Immune Responses (1 paper), Polyomavirus and related diseases (1 paper) and Cystic Fibrosis Research Advances (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (121 citations), Pharmacy (13 citations), General Dentistry (4 citations), Pharmaceutical Science (14 citations) and Critical Care and Intensive Care Medicine (5 citations). Andrew O’Sullivan has collaborated with scholars based in Ireland, United States and United Kingdom. Frequent co-authors include Ronan MacLoughlin, Mary Joyce, James A. McGrath, Gerry Oster, John Edelsberg, Miriam Byrne, David R. Thompson, Marc Mac Giolla Eain, Sarinj Fattah and Elena Fernández Fernández. Their work appears in journals such as Pharmaceutics, Frontiers in Medicine, Antibiotics, Vaccines and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.